Adobe

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also the author of the Health Care Inc. newsletter. You can reach Bob on Signal at bobjherman.09.

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

Apparently, some vets are already using GLP-1s for diabetic cats. We are all a clinical trial or two away from “Ozempets” becoming mainstream. But do we really want our pets to shun the treats we give them? Tips and pet thoughts here: [email protected].

Advertisement

The crushing weight of drugs, especially GLP-1s  

For the past two-plus years, health insurers have been up to their necks in medical claims. Prices are higher. People are seeing their doctors more. All types of care are elevated, which is thinning insurers’ profit margins.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe